메뉴 건너뛰기




Volumn 117, Issue 3, 2000, Pages 870-874

Anorexigens and pulmonary hypertension in the United States: Results from the surveillance of North American pulmonary hypertension

Author keywords

Anorexigens; Diet pills; Fenfluramines; Pulmonary hypertension

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE;

EID: 0034118327     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.117.3.870     Document Type: Article
Times cited : (172)

References (11)
  • 1
    • 0021986849 scopus 로고
    • Aminorex and pulmonary hypertension
    • 1 Gurtner HP. Aminorex and pulmonary hypertension. Cor Vasa 1985; 27:160-171
    • (1985) Cor Vasa , vol.27 , pp. 160-171
    • Gurtner, H.P.1
  • 2
    • 0015062295 scopus 로고
    • Aminorex and the pulmonary circulation
    • 2 Kay JM, Smith P, Heath D. Aminorex and the pulmonary circulation. Thorax 1971; 26:262-269
    • (1971) Thorax , vol.26 , pp. 262-269
    • Kay, J.M.1    Smith, P.2    Heath, D.3
  • 3
    • 0019369617 scopus 로고
    • Pulmonary hypertension and fenfluramine
    • 3 Douglas JG, Munro JF, Kitchin AH, et al. Pulmonary hypertension and fenfluramine. BMJ 1981; 283:881-883
    • (1981) BMJ , vol.283 , pp. 881-883
    • Douglas, J.G.1    Munro, J.F.2    Kitchin, A.H.3
  • 5
    • 0022578684 scopus 로고
    • Irreversible pulmonary hypertension after treatment with fenfluramine
    • 5 McMurray J, Bloomfield P, Miller HC. Irreversible pulmonary hypertension after treatment with fenfluramine [letter]. BMJ 1986; 293:51-52
    • (1986) BMJ , vol.293 , pp. 51-52
    • McMurray, J.1    Bloomfield, P.2    Miller, H.C.3
  • 6
    • 0022591466 scopus 로고
    • Irreversible pulmonary hypertension after treatment with fenfluramine
    • 6 Watters K, Le Ridant A. Irreversible pulmonary hypertension after treatment with fenfluramine [letter]. BMJ 1986; 292: 1137
    • (1986) BMJ , vol.292 , pp. 1137
    • Watters, K.1    Le Ridant, A.2
  • 7
    • 0027135052 scopus 로고
    • Primary pulmonary hypertension and fenfluramine use
    • 7 Brenot F, Herve P, Petitpretz P, et al. Primary pulmonary hypertension and fenfluramine use. Br Heart J 1993; 70:537-541
    • (1993) Br Heart J , vol.70 , pp. 537-541
    • Brenot, F.1    Herve, P.2    Petitpretz, P.3
  • 8
    • 0031844306 scopus 로고    scopus 로고
    • High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium
    • 8 Delcroix M, Kurz X, Walckiers D, et al. High incidence of primary pulmonary hypertension associated with appetite suppressants in Belgium. Eur Respir J 1998; 12:271-6
    • (1998) Eur Respir J , vol.12 , pp. 271-276
    • Delcroix, M.1    Kurz, X.2    Walckiers, D.3
  • 9
    • 9444287592 scopus 로고    scopus 로고
    • Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    • 9 Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996; 335:609-616
    • (1996) N Engl J Med , vol.335 , pp. 609-616
    • Abenhaim, L.1    Moride, Y.2    Brenot, F.3
  • 10
    • 0030853476 scopus 로고    scopus 로고
    • Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine
    • 10 Mark EJ, Patalas ED, Chang HT, et al. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine. N Engl J Med 1997; 337:602-606
    • (1997) N Engl J Med , vol.337 , pp. 602-606
    • Mark, E.J.1    Patalas, E.D.2    Chang, H.T.3
  • 11
    • 0023615359 scopus 로고
    • Primary pulmonary hypertension: A national prospective study
    • 11 Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107:216-223
    • (1987) Ann Intern Med , vol.107 , pp. 216-223
    • Rich, S.1    Dantzker, D.R.2    Ayres, S.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.